Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00341588 · ClinicalTrials.gov registry record

A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen

A clinical trial, sponsored by National Cancer Institute (NCI).

Completed
Registry status
2,772
Enrollment target

NCT00341588: Completed study, sponsored by National Cancer Institute (NCI).

NCT00341588 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 2,772 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00341588 has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
2,772 participants
Enrollment target

Study Summary

The incidence of testicular germ cell tumors (TGCT) has increased during the twentieth century and is of particular concern as it primarily affects young men. It is the most common cancer among U.S. males ages 25-34. The only well-described risk factors are cryptorchism (undescended testis), family history of TGCT, and personal history of TGCT. To better understand the environmental and genetic determinants of TGCT risk, a case-control study will be conducted among members of the U.S. armed forces. The study will include men who have donated a blood sample to the Department of Defense Serum Repository (DoDSR) between 1989 and 2000. All DoDSR donors who have developed GCT will be matched to DoDSR donors who have not developed TGCT. Approximately 1,080 men with TGCT, 1,080 controls, and 2,160 mothers will be included in the study. The DoDSR serum sample will be tested for organochlorines levels, gonadotropin levels, and viral antibody titres. Each participant will donate a saliva specimen that will be used in an examination of genetic susceptibility. Each participant will also complete a questionnaire concerning a variety of possible risk factors such as physical activity, medical history, medication history, and other risk factors. The mothers of all participants will be invited to participate by completing a questionnaire concerning perinatal exposures and events and by donating a saliva sample. The three main objectives of this study are to: * determine whether environmental endocrine modulators (i.e., chlorinated pesticides and polychlorinated biphenyls) are related to risk of GCT and, if so, whether their effects are augmented by other risk factors. * determine whether genetic susceptibility to GCT exists and to characterize the environmental risk factors related to that susceptibility. * determine whether there are distinct causes of GCT by relating the tissue structures of the tumors to the risk factors.

Trial Details

FieldValue
Enrollment Target 2,772 participants
Start Date 2002-01-18
Est. Completion 2020-08-18
National Cancer Institute (NCI)

3,257 total trials

What the finished NCT00341588 record still lists

NCT00341588 is an observational study that tracks outcomes without assigning an intervention. Its 2,772 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT00341588 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00341588 about?

NCT00341588 is a clinical study titled "A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen". The incidence of testicular germ cell tumors (TGCT) has increased during the twentieth century and is of particular concern as it primarily affects young men. It is the most common cancer among U.S. males ages 25-34. The only well-described risk factors are cryptorchism (undescended testis), family ...

What is the current status of trial NCT00341588?

This trial is currently completed. The enrollment target is 2,772 participants. The study started on 2002-01-18. Estimated completion is 2020-08-18.

Who is sponsoring clinical trial NCT00341588?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05443737 · 2,800 participants · Phase 3

    Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients

  • NCT05899439 · 2,800 participants

    Immune Function and the Progression to T1D

  • NCT06089109 · 2,800 participants · NA

    Creating VIP Corps to Reduce Maternal Deaths

  • NCT06345339 · 2,800 participants · Phase 2

    A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00341588, the US trial registry maintained by the National Library of Medicine. NCT00341588 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.